RL
Richard Law Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
53.3%
Neutral
33.3%
Negative
13.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $95 |
2%
upside
| 1 | – |
–
| 3 Mar ‘26 3 months ago |
|
|
|
Sell
Maintained
| $3 |
4%
upside
| 2 | +3.2% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $34 |
18%
upside
| 2 | – |
–
| 2 Mar ‘26 3 months ago |
|
|
|
Sell
Downgraded
| $10 |
44%
downside
| 2 | -32% |
0
%
| 15 Jan ‘26 4 months ago |
|
|
|
Buy
Upgraded
| $28 |
14%
upside
| 1 | +6.6% |
0
%
| 13 Jan ‘26 4 months ago |
|
|
|
Buy
Upgraded
| $67 |
105%
upside
| 2 | -28% |
0
%
| 12 Jan ‘26 4 months ago |
|
|
|
Buy
Maintained
| $38 |
255%
upside
| 3 | +121% |
0
%
| 11 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $135 |
48%
upside
| 1 | -7.4% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $29 |
39%
upside
| 2 | – |
–
| 30 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $52 |
80%
upside
| 1 | -28% |
0
%
| 9 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $30 |
89%
upside
| 2 | +56% |
0
%
| 7 Aug ‘25 9 months ago |
|